MEMPHASYS LIMITED. — Investor Relations & Filings
Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Updated Securities Trading Policy 14 pages 542.2KB | 2026-05-03 | English | |
| Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 1.3MB | 2026-04-16 | English | |
| Investor Presentation - April 2026 20 pages 1.8MB | 2026-04-06 | English | |
| Memphasys Investor Webinar 2 pages 275.0KB | 2026-04-01 | English | |
| MENA Orders Secured, Expanded & Operations Unaffected 4 pages 352.5KB | 2026-03-19 | English | |
| Appendix 4D - Half-year Financial Report - 31 December 2025 21 pages 1.1MB | 2026-02-26 | English |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NewAmsterdam Pharma Co N.V.
A clinical-stage biopharma developing therapies for metabol…
|
NAMS | NL | Professional, scientific and te… |
|
NEXALIS THERAPEUTICS LTD
Develops small molecule therapies for chronic inflammatory …
|
NX1 | AU | Professional, scientific and te… |
|
NextGen Biomed Ltd.
Develops novel therapeutic delivery systems and pain-free a…
|
NXGN | IL | Professional, scientific and te… |
|
NEXTURNBIOSCIENCE Co., LTD
Manufacturer of CNC automatic lathes and ultra-precision co…
|
089140 | KR | Professional, scientific and te… |
|
NFL Biosciences
Biopharmaceutical company developing botanical drug candida…
|
ALNFL | FR | Professional, scientific and te… |
|
NGeneBio Co., Ltd.
Develops NGS-based molecular diagnostic products and softwa…
|
354200 | KR | Professional, scientific and te… |
|
Nicox S.A.
Ophthalmology company developing therapies based on a nitri…
|
COX | FR | Professional, scientific and te… |
|
Nirvana Life Sciences Inc
Developing non-addictive psilocybin therapeutics to treat a…
|
NIRV | CA | Professional, scientific and te… |
|
NLS Pharmaceutics Ltd.
Clinical-stage biopharma firm developing therapies for rare…
|
NLSP | US | Professional, scientific and te… |
|
NovoCure Ltd
Develops a non-invasive cancer therapy using electric field…
|
NVCR | JE | Professional, scientific and te… |
MEMPHASYS LIMITED. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/65314/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=65314 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=65314 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=65314 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 65314}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MEMPHASYS LIMITED. (id: 65314)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.